Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group
暂无分享,去创建一个
R. Willemze | Z. Berneman | W. Feremans | B. Labar | S. Suciu | G. Fillet | S. Amadori | D. Bron | G. Vreugdenhil | M. Mistrik | P. Muus | B. Jakšić | R. de Bock | D. Nemet | J. Marie | H. Sinnige | C. Gilotay | T. D. de Witte
[1] G. Decorti,et al. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: Role of polymorphisms of genes involved in glucocorticoid response , 2009, Pediatric blood & cancer.
[2] M. Grootenhuis,et al. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study , 2008, Health and quality of life outcomes.
[3] B. Labar,et al. Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation? , 2007, Seminars in hematology.
[4] D. Campana,et al. Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia , 2007, Leukemia.
[5] I. Langner. Survival Analysis: Techniques for Censored and Truncated Data , 2006 .
[6] C. Pui,et al. Treatment of acute lymphoblastic leukemia. , 2006, The New England journal of medicine.
[7] M. Tallman,et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. , 2005, Blood.
[8] T. Lipp,et al. Dexamethasone Dose and Schedule Significantly Influences Remission Rate and Toxicity of Induction Therapy in Adult Acute Lymphoblastic Leukemia (ALL): Results of the GMALL Pilot Trial 06/99. , 2005 .
[9] S. Richards,et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial , 2005, British journal of haematology.
[10] H. Kantarjian,et al. Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia , 2004, Cancer.
[11] M. Saleh,et al. Dexamethasone‐associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin , 2003, Cancer.
[12] N. Heerema,et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 2003, Blood.
[13] R. Gelber,et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.
[14] P. Hesseling,et al. PROGNOSTIC VALUE OF DAY 14 BLAST PERCENTAGE AND THE ABSOLUTE BLAST INDEX IN BONE MARROW OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA , 2001, Pediatric hematology and oncology.
[15] C. Pui,et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia , 2000, Leukemia.
[16] T. Lipp,et al. Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). , 2000, Hematology/oncology clinics of North America.
[17] D. Hoelzer,et al. Recent approaches in acute lymphoblastic leukemia in adults. , 2000, Reviews in clinical and experimental hematology.
[18] R. Gelber,et al. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia , 2000, Cancer.
[19] A. Vora,et al. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials , 2000, Leukemia.
[20] J. Klein,et al. Survival Analysis: Techniques for Censored and Truncated Data , 1997 .
[21] R. Pieters,et al. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. , 1996, Medical and pediatric oncology.
[22] D. Campana,et al. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] W. Kamps,et al. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Gaynon,et al. The Use of Glucocorticoids in Acute Lymphoblastic Leukemia of Childhood Molecular, Cellular, and Clinical Considerations , 1995, Journal of pediatric hematology/oncology.
[25] C. Haanen,et al. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. , 1994, Bone marrow transplantation.
[26] G. Chrousos,et al. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[28] S. Waltman,et al. In vitro determination of relative corticosteroid potency. , 1975, The Journal of clinical endocrinology and metabolism.
[29] L. Sinks. Treatment of acute lymphoblastic leukaemia. , 1972, Archives of disease in childhood.
[30] F. Giles,et al. Treatment of Acute Lymphoblastic Leukaemia , 2012, Drugs.
[31] J. Bourhis,et al. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin’s lymphoma for patients ≤£ 50 years old in first complete remission: results of the EORTC ALL-3 trial , 2004 .
[32] C. Pui,et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] J. Shuster,et al. Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. , 1991, Medical and pediatric oncology.
[34] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .